Martine Moreau

1.8k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

Martine Moreau is a scholar working on Surgery, Cancer Research and Immunology. According to data from OpenAlex, Martine Moreau has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Martine Moreau's work include Cholesterol and Lipid Metabolism (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Hepatitis C virus research (5 papers). Martine Moreau is often cited by papers focused on Cholesterol and Lipid Metabolism (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Hepatitis C virus research (5 papers). Martine Moreau collaborates with scholars based in France, Italy and United Kingdom. Martine Moreau's co-authors include Thierry Huby, Philippe Lesnik, M. John Chapman, Laure Petit, Mustapha Rouis, John Chapman, Ewa Ninio, Isabelle Brochériou, Charles M. Rice and Wilfried Le Goff and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Martine Moreau

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis

2020 256 citations Sophie Tran, Lucie Poupel et al. Immunity profile →

Peers

Countries citing papers authored by Martine Moreau

Since Specialization

Citations

This map shows the geographic impact of Martine Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine Moreau more than expected).

Fields of papers citing papers by Martine Moreau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine Moreau. The network helps show where Martine Moreau may publish in the future.

Co-authorship network of co-authors of Martine Moreau

This figure shows the co-authorship network connecting the top 25 collaborators of Martine Moreau. A scholar is included among the top collaborators of Martine Moreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine Moreau. Martine Moreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of embryonically-derived Kupffer cells during hypercholesterolemia accelerates atherosclerosis development 2024 ·Nature Communications ·(unknown), Sébastien Dussaud, (unknown), (unknown), (unknown), Lucie Poupel, (unknown), Adélaïde Gélineau, (unknown), (unknown), (unknown), Martine Moreau, Alexandre Boissonnas, Emmanuel L. Gautier, Thierry Huby	5
2	High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects 2020 ·International Journal of Molecular Sciences ·Alexy Tran‐Dinh, Angélique Levoye, C. David, Lauriane Galle-Treger, Martine Moreau, Sandrine Delbosc, (unknown), Philippe Montravers, Pierre Amarenco, Thierry Huby, Olivier Meilhac	21
3	Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis breakdown → 2020 ·Immunity ·Sophie Tran, (unknown), Lucie Poupel, Sébastien Dussaud, Martine Moreau, Adélaïde Gélineau, Geneviève Marcelin, (unknown), (unknown), Philippe Lesnik, Alexandre Boissonnas, Wilfried Le Goff, Björn E. Clausen, Laurent Yvan‐Charvet, Florian Sennlaub, Thierry Huby, Emmanuel L. Gautier	256
4	Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis 2019 ·Cardiovascular Research ·Lauriane Galle-Treger, Martine Moreau, Raphaëlle Ballaire, Lucie Poupel, (unknown), Emanuele Sasso, Fulvia Troise, Francesco Potì, Philippe Lesnik, Wilfried Le Goff, Emmanuel L. Gautier, Thierry Huby	21
5	Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis 2011 ·Journal of Biological Chemistry ·(unknown), (unknown), Martine Moreau, Flora Saint-Charles, (unknown), Francesco Potì, M. John Chapman, Wilfried Le Goff, Philippe Lesnik, Thierry Huby	39
6	Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha 2009 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Xavier Prieur, Philippe Lesnik, Martine Moreau, Joan Rodríguez, Chantal Doucet, M. John Chapman, Thierry Huby	15
7	Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants 2009 ·Journal of Virology ·Maria Teresa Catanese, Helenia Ansuini, Rita Graziani, Thierry Huby, Martine Moreau, Jonathan K. Ball, Giacomo Paonessa, Charles M. Rice, Riccardo Cortese, Alessandra Vitelli, Alfredo Nicosia	121
8	Scavenger Receptor BI Boosts Hepatocyte Permissiveness to Plasmodium Infection 2008 ·Cell Host & Microbe ·(unknown), Thierry Huby, Jean‐François Franetich, Audrey Gego, Armelle Rametti‐Lacroux, Martine Moreau, Xavier Collet, Anthony Siau, Geert‐Jan van Gemert, Robert W. Sauerwein, Adrian J. F. Luty, Jean‐Christophe Vaillant, L Hannoun, John Chapman, Dominique Mazier, (unknown)	87
9	Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity 2007 ·Journal of Virology ·Joe Grove, Thierry Huby, Zania Stamataki, Thomas Vanwolleghem, Philip Meuleman, Michelle J. Farquhar, (unknown), Martine Moreau, James S. Owen, Geert Leroux‐Roels, Peter Balfe, Jane A. McKeating	115
10	High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein 2007 ·Journal of Virology ·Maria Teresa Catanese, Rita Graziani, Thomas von Hahn, Martine Moreau, Thierry Huby, Giacomo Paonessa, Claudia Santini, Alessandra Luzzago, Charles M. Rice, Riccardo Cortese, Alessandra Vitelli, Alfredo Nicosia	117
11	LDL particle subspecies are distinct in their capacity to mediate free cholesterol efflux via the SR-BI/Cla-1 receptor 2006 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·(unknown), Martine Moreau, Andrei C. Spósito, M. John Chapman, Thierry Huby	19
12	Apolipoprotein E Knockout Mice Over-Expressing Human Tissue Inhibitor of Metalloproteinase 1 Are Protected against Aneurysm Formation but Not against Atherosclerotic Plaque Development 2006 ·Journal of Vascular Research ·(unknown), (unknown), Guilhem Larigauderie, (unknown), Christophe Furman, Martine Moreau, M. John Chapman, Jean‐Charles Fruchart, Mohamed Naceur Slimane, Hafid Mezdour, Mustapha Rouis	18
13	The interaction of natural hepatitis C virus with human scavenger receptor SR‐BI/Cla1 is mediated by ApoB‐containing lipoproteins 2006 ·The FASEB Journal ·Patrick Maillard, Thierry Huby, Ursula Andréo, Martine Moreau, John Chapman, Agata Budkowska	118
14	Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability 2004 ·Atherosclerosis ·Christophe Furman, Corinne Copin, (unknown), Robert G. Davidson, Martine Moreau, (unknown), M. John Chapman, Jean‐Charles Fruchart, Mustapha Rouis	76
15	The Promoter of Human Tissue Factor Pathway Inhibitor Gene 1999 ·Thrombosis Research ·Laure Petit, Philippe Lesnik, Christiane Dachet, (unknown), Martine Moreau, John Chapman, Mustapha Rouis	11
16	Interleukin-8 Mediates Downregulation of Tissue Inhibitor of Metalloproteinase-1 Expression in Cholesterol-Loaded Human Macrophages 1999 ·Circulation ·Martine Moreau, Isabelle Brochériou, Laure Petit, Ewa Ninio, M. John Chapman, Mustapha Rouis	151
17	Impact of a Combination of a Calcium Antagonist and a β-Blocker on Cell- and Copper-Mediated Oxidation of LDL and on the Accumulation and Efflux of Cholesterol in Human Macrophages and Murine J774 Cells 1997 ·Arteriosclerosis Thrombosis and Vascular Biology ·Philippe Lesnik, Christiane Dachet, Laure Petit, Martine Moreau, S. Griglio, Philippe Brudi, M. John Chapman	25
18	Tissue Factor Pathway Inhibitor Activity Associated With LDL Is Inactivated by Cell- and Copper-Mediated Oxidation 1995 ·Arteriosclerosis Thrombosis and Vascular Biology ·Philippe Lesnik, (unknown), Alin Vonica, Martine Moreau, M. John Chapman	27
19	Cyclic AMP decseases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2 1988 ·Biochemical and Biophysical Research Communications ·Cécile Mazière, (unknown), Suzanne Salmon, Martine Auclair, Liliana Mora, Martine Moreau, J. Polonovski	13
20	Modifications of Collagens in the Course of Inflammatory Tracheal Stenoses 1985 ·Annals of Otology Rhinology & Laryngology ·Georges Bellon, Martine Moreau, (unknown), Jacques P. Borel, A Randoux, Michel Legros, (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact